Biological Indicator Reduced Incubation Time (RIT) Presented by: Andrew Melloy
|
|
- Leo Harrington
- 5 years ago
- Views:
Transcription
1 Biological Indicator Reduced Incubation Time (RIT) Presented by: Andrew Melloy
2 BIOLOGICAL INDICATOR A device containing calibrated bacterial spores used to monitor the adequacy of sterilization processes Geobacillus stearothermophilus Bacillus atrophaeus
3 REDUCED INCUBATION TIME (RIT) 7 day Incubation 48-hour RIT 24-hour RIT 10-hour RIT
4 REDUCED INCUBATION TIME (RIT) Biological indicator results are not immediate, they require time for incubation of the viable microorganisms so we can determine if they have survived the process
5 REDUCED INCUBATION TIME (RIT) For how long do these samples need to be incubated? ISO days for established sterilization processes (such as moist heat and ethylene oxide) 14-day for novel sterilization methods
6 REDUCED INCUBATION TIME (RIT) The concept of reduced incubation time is to determine a minimum amount of time necessary to achieve valid results These RITs are developed using a guidance set forth by the FDA s Center for Device and Radiological Health (CDRH) in The document Guidance for Industry and FDA Staff - Biological Indicator (BI) Premarket Notification 510(k) Submissions establishes a test protocol for qualifying reduced incubation times
7 REDUCED INCUBATION TIME The US FDA protocol is the only recognized protocol to reduce the incubation time for culturing BIs Assay is required for BI manufacturers who want to reduce the incubation time label claim to < 7 days While the CDRH guidance is directed toward biological indicators used in Healthcare facilities historically it has generally been adopted by the manufacturing industry as well.
8 REDUCED INCUBATION TIME Assay determines the appropriate amount of time needed to recover low numbers of injured spores
9 REQUIREMENTS OF THE FDA RIT TEST PROTOCOL The guidance requires BI manufacturers to expose a total of 100 BIs to partial conditions in the appropriate sterilization process that produce a mixture of BIs that are positive and negative for growth The guidance requires that the overall number of positive BIs from each lot be within the range of 30-80% of the total number of BI s
10 REQUIREMENTS OF THE FDA RIT TEST PROTOCOL The RIT is the time where 97% of the growthpositive results are observed compared to the 7 day total value The protocol must be reproduced with 3 lots of BIs ( 3 x 100 units)
11 REQUIREMENTS OF THE FDA RIT TEST PROTOCOL Those BIs are graded daily and at the end of the seven (7) day incubation period. The daily results are compared against the final result at seven (7) days Using the number of BIs that test positive on day 7 as the base of 100% grow out, the greatest number of days of incubation time to obtain more than 97% positive BIs (based on the 7-day incubation time) in any one of the three lots is the minimum incubation time for the BI
12 RIT QUALIFICATION TESTING
13 REDUCED INCUBATION TIME The US FDA RIT test protocol is NOT globally accepted Currently there is no universal RIT standard
14 REDUCED INCUBATION TIME The more spores present on the BI, the faster the growth-positive result will be detected
15 POSITIVE CONTROLS (10 5 SPORES/BI) INCUBATION TIME # of Positive Units Positive Controls (10 5 ) Time (Hours)
16 SUB-LETHAL EXPOSED UNITS BETWEEN 10 4 AND 10 2 SPORES/BI # of Positive Units Positive Controls Sublethal Exposure (10 5 ) ( ) Time (Hours)
17 SUB-LETHAL EXPOSED UNITS BETWEEN 10 1 AND 10 0 SPORES/BI # of Positives Units Positive Controls Sublethal Exposure 1-10 Spores (10 5 ) ( ) ( ) Time (Hours)
18 QUANTAL ZONE (FDA RIT PROTOCOL) BETWEEN 30 TO 80 POSITIVE BIS PER 100 TESTED # of Positive Units Positive Controls Sublethal Exposure 1-10 Spores (10 5 ) ( ) ( ) 30-80% (+) FDA RIT Protocol Time (Hours)
19 REDUCED INCUBATION TIME Delayed grow-out is the result of a BI with only ONE viable but damaged spore a HIGHLY improbable event in a production sterilizer
20 TIME TO POSITIVE INCUBATION TEST Geobacillus stearothermophilus Time To Positive Incubation Test Positive Controls 3:12 Mean Time to Positive in White Sublethal Exposure 3: Spores 5:16 RIT 6: Time (hours)
21 REDUCED INCUBATION TIME CDER (Centre for Drug Evaluation and Research) is indicating that manufacturers of sterile drug products should adhere to the 7-day recommendation that appears in ISO : Sterilization of healthcare products Biological indicators-part 1: General Requirements states the following in sections and 7.3.2: The incubation time and temperature shall be validated BI manufacturer shall provide instructions for incubation
22 REDUCED INCUBATION TIME FDA CDER (Center for Drug Evaluation and Research) might not necessarily endorse or condone the test protocol published by the FDA CDRH; citing that the test parameters set forth in the CDRH protocol are applicable for BIs used to monitor sterilization processes in healthcare facilities, but are not appropriate for BIs that are used in a manufacturing setting. CDER does not generally recognize the acceptance criterion that the minimum incubation time is the greatest number of days to obtain more than 97% positive BIs subjected to a partial cycle.
23 REDUCED INCUBATION TIME ISO 14161: Sterilization of healthcare products biological indicators-guidance for selection, use and interpretation of results section acknowledges that a BI manufacturer may validate a reduced incubation time that does not have to be repeated by the end user as long as the end user uses the BI in the same sterilizing agent for which the BI was designed and validated
24 REDUCED INCUBATION TIME BI users in the Pharmaceutical/manufacturing industry would be prudent to disregard that which appears in ANSI/AAMI/ISO 14161, section and incubate their exposed BIs for a full seven days BI users in the pharmaceutical/manufacturing industry might choose to incubate and score the BIs at the reduced incubation time that appears in the instructions and keep the BIs incubating for the remainder of the 7-day period at which time the BIs are again scored for results.
25 ISO TC 198 WG 4 MINIMUM INCUBATION TIME - MIT Understanding BI Grow Out Times, Part I (January 2010): Biological-Indicator-Grow-Out-Times/ArticleStandard/Article/detail/ Understanding BI Grow Out Times, Part II (June 2013): Indicator-Grow-Out-Timesm/ArticleStandard/Article/detail/ Historical Perspective (May 2012): Indicator-Growout-Times-The-Impact-on-E/ArticleStandard/Article/detail/ Establishing a Minimum Incubation Time for Biological Indicators, Part III (Dec 2013): Minimum-Incubation-Time-for-Biologi/ArticleStandard/Article/detail/830014
26 ANTICIPATED RESULTS Present to ISO a database statistically analyzed protocol that focuses on the expected levels of contamination not the last survivor Reduce the required incubation time for BIs to less than occurs with the FDA protocol so their results are timely Direct thinking to focus on the first positive not the last positive
27 ANTICIPATED RESULTS Enhance the perception that the BIs are an essential tool that should be used more diligently Provide regulatory agencies and notified bodies with a globally harmonized standard
28 IN CONCLUSION Reduced Incubation time means faster results and potential release of product however you must take into account your regulatory environment ISO is currently working on Minimum Incubation Time (MIT) standards as a replacement for the current RIT
29 ANY FURTHER QUESTIONS? Thank You!
STERILIZATION VALIDATION IN THIS SECTION REPROCESSING VALIDATIONS FOR REUSABLE MEDICAL DEVICES. Radiation Sterilization Validation
STERILIZATION VALIDATION All sterilization processes require validation of the efficacy and reproducibility of the process. Depending on the type of sterilization, this may be accomplished by partial,
More informationPRODUCT D-VALUE STUDIES: A CRITICAL TOOL WHEN DEVELOPING A STERILIZATION PROCESS
Volume 1, Number 3 June 2004 PRODUCT D-VALUE STUDIES: A CRITICAL TOOL WHEN DEVELOPING A STERILIZATION PROCESS Kurt McCauley R & D Lab Manager The objective of a sterilization process is to kill the naturally
More informationDUAL SPECIES BIOLOGICAL INDICATOR SPORE STRIPS For Monitoring Ethylene Oxide (EO), Steam and Chemiclave Processes
DUAL SPECIES BIOLOGICAL INDICATOR SPORE STRIPS For Monitoring Ethylene Oxide (EO), Steam and Chemiclave Processes Reorder Code: STNS-65R Product Description Dual Species Biological Indicator Spore Strips
More informationBiological Indicators and Their Application in Clinical Sterilization Spores Don t Lie 1
Biological Indicators and Their Application in Clinical Sterilization 2010 Spores Don t Lie 1 SGM Biotech, Inc. 10 Evergreen Drive, Suite E Bozeman, MT 59715 Tel: 406-585-9535 Fax: 406-585-9219 email:
More informationChemical Indicators. Biological Indicators. Physical Monitors. Welcome! How do I get a CE Certificate? Learning Objectives
3M Infection Prevention Solutions 3M Sterile U Web Meeting July 17, 2014 The Science of Speed The Evolution of Biological Indicators Welcome! Topic: The Science of Speed The Evolution of Biological Indicators
More informationSterilAmp II Geobacillus stearothermophilus
SterilAmp II Geobacillus stearothermophilus TECHNICAL REPORT Complies to USP, ISO 11138, and all appropriate subsections Technical Data and Use of SterilAmp II Part #7709 Rev.5 25FEB14 Page 1 of 6 INTRODUCTION
More informationCurrent Topics For Sterile Generic Drug Products
Current Topics For Sterile Generic Drug Products Marla Stevens-Riley, Ph.D. Team Leader Division of Microbiology for ANDA Review FDA/CDER GPHA CMC Workshop June 4, 2014 Disclaimer Opinions expressed in
More informationISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 14161 Second edition 2009-09-15 Sterilization of health care products Biological indicators Guidance for the selection, use and interpretation of results Stérilisation des produits
More informationISO INTERNATIONAL STANDARD
Provläsningsexemplar / Preview INTERNATIONAL STANDARD ISO 11138-3 Second edition 2006-07-01 Sterilization of health care products Biological indicators Part 3: Biological indicators for moist heat sterilization
More informationTechnical Data Monograph. VERIFY Assert Self-Contained Biological Indicators and VERIFY Assert STEAM Process Challenge Devices
Technical Data Monograph VERIFY Assert Self-Contained Biological Indicators and VERIFY Assert STEAM Process Challenge Devices Table of Contents 1. Introduction....3 2. Product Use Application...4 Device
More informationGuidance for IRBs, Clinical Investigators and Sponsors
Guidance for IRBs, Clinical Investigators and Sponsors IRB Responsibilities for Reviewing the Qualifications of Investigators, Adequacy of Research Sites, and the Determination of Whether an IND/IDE is
More informationASTM D10-F02 Workshop FDA Regulatory Perspective. Patrick Weixel FDA Center for Devices and Radiological Health
ASTM D10-F02 Workshop FDA Regulatory Perspective Patrick Weixel FDA Center for Devices and Radiological Health 1 FDA Regulatory Perspective Focus of talk: Use of Standards Auditing Packaging Process Deficiencies
More informationGuidance for Industry
Guidance for Industry for the Submission Documentation for Sterilization Process Validation in Applications for Human and Veterinary Drug Products Center for Drug Evaluation and Research (CDER) Center
More informationThis document is a preview generated by EVS
INTERNATIONAL STANDARD ISO 11135 Second edition 2014-07-15 Sterilization of health-care products Ethylene oxide Requirements for the development, validation and routine control of a sterilization process
More informationBiological Monitoring
Biological Monitoring Prof. Duygu PERÇİN, MD Department of Clinical Microbiology Erciyes University Faculty of Medicine, Kayseri-TURKEY duygu.percin@hotmail.com Learning Objectives The attandee will be
More informationISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 14161 First edition 2000-10-01 Sterilization of health care products Biological indicators Guidance for the selection, use and interpretation of results Stérilisation des produits
More informationSterilization - validation, qualification requirements. Sterilization - Overview
Sterilization - validation, qualification requirements Dawn Tavalsky 1 ISPE Boston Chapter Framingham MA 19Sep2013 Sterilization - Overview Objectives Discuss definition of Sterile Briefly describe sterilization
More informationBiological and chemical indicators
Medical Market Laboratory EMEA Space for 3M Montage Biological and chemical indicators Josephus P.C.M van Doornmalen Gomez Hoyos Croatia, March 28, 2009) Outline Sterilization definitions Purpose of monitoring
More informationParametric Release An Industry Perspective. October 22, Mike Sadowski Director Sterile Manufacture Support Baxter Healthcare Corporation
Parametric Release An Industry Perspective October 22, 2010 Mike Sadowski Director Sterile Manufacture Support Baxter Healthcare Corporation Presentation Overview 1. Definitions of Parametric Release 2.
More informationapplying a unique combination of disciplines consulting, preclinical, toxicology,
NAMSA is a Medical Research Organization (MRO), accelerating product development through integrated laboratory, clinical and consulting services. Driven by our regulatory expertise, NAMSA's MRO Approach
More informationCERTIFICATE OF ACCREDITATION
CERTIFICATE OF ACCREDITATION ANSI-ASQ National Accreditation Board 500 Montgomery Street, Suite 625, Alexandria, VA 22314, 877-344-3044 This is to certify that Dynatec Scientific Laboratories, Inc. 11940
More informationTHE TERMS VALIDATION AND VERIFICATION ARE FREQUENTLY
Lesson No. CRCST 162 (Technical Continuing Education - TCE) Sponsored by: by Susan Klacik, BS, CRCST, ACE, CIS, FCS IAHCSMM Clinical Educator Validation and Verification LEARNING OBJECTIVES 1. Describe
More information5.1.1 & Changes started in 2008 and were mainly driven under the Chairmanship of Prof Hans van Doorne 11/10/2017
5.1.1 & 5.1.2 V Iain Fenton-May Chairman Group 1 Methods of Preparation of Sterile Products Changes started in 2008 and were mainly driven under the Chairmanship of Prof Hans van Doorne 1 Methods of Preparation
More informationSummary of Proposed Legislative Provisions
Summary of Proposed Legislative Provisions The evidence obtained by the Committee on Oversight and Government Reform during its investigation of duodenoscope-related patient infections identified significant
More informationCERTIFICATE OF ACCREDITATION
CERTIFICATE OF ACCREDITATION ANSI National Accreditation Board 11617 Coldwater Road, Fort Wayne, IN 46845 USA This is to certify that Dynatec Scientific Laboratories, Inc. 11940 Golden Gate Road El Paso,
More informationImpact of Culture Media on Biological Indicator Spore Recovery
Volume 4, Number 1 January 2007 Impact of Culture Media on Biological Indicator Spore Recovery Kellie Matzinger Spore Lab Supervisor The D-value of a specific biological indicator is significantly influenced
More informationREUSABLE MEDICAL DEVICE VALIDATION
All sterilization processes require validation of the efficacy and reproducibility of the process. Depending on the type of sterilization, this may be accomplished by partial, sub-lethal, or repetitive
More informationMANAGING INFECTION CONTROL
To Kill or A biological indicator story Not to Kill by Sailaja Chandrapati, BS, MSc, MS, PhD, and Martha Young, BS, MS, CSPDT Objectives 1. Explain the historical evolution of the role of bacterial spores
More informationISO INTERNATIONAL STANDARD
Provläsningsexemplar / Preview INTERNATIONAL STANDARD ISO 11138-4 First edition 2006-07-01 Sterilization of health care products Biological indicators Part 4: Biological indicators for dry heat sterilization
More informationSoleris system evaluation of testing applications for UHT/aseptic packs
Summary system evaluation of testing applications for UHT/aseptic packs September 2012 Neogen Corporation (Lansing, Mich.) conducted internal studies to validate optimal test procedures for the ultrahigh
More informationPurchasing Controls. FDA Small Business Regulatory Education for Industry (REdI) Conference Denver, Colorado May 13, 2015
Purchasing Controls FDA Small Business Regulatory Education for Industry (REdI) Conference Denver, Colorado May 13, 2015 LCDR Samantha Spindel, Ph.D. Premarket Programs Branch Division of Industry and
More informationQuality Control LOAD CONTROL. VERIFY Load Control Products. Use to monitor and release instrumentation with confidence RECORD KEEPING & LABELING
STERILITY ASSURANCE Use to monitor and release instrumentation with confidence VERIFY Load Control Products LOAD CONTROL PROCESS CONTROL PACK CONTROL EQUIPMENT CONTROL RECORD KEEPING & LABELING PRODUCT
More informationUSE OF PHANTOMS AND IMAGE DATASETS FOR
USE OF PHANTOMS AND IMAGE DATASETS FOR REGULATORY DECISION MAKING Nicholas Petrick. Ph.D. Division of Imaging, Diagnostics and Software Reliability (DIDSR) Office of Science and Engineering Labs Center
More informationThe Ethylene Oxide Sterilization Association, Inc. Managed by B&C Consortia Management, L.L.C. POSITION STATEMENT. May 20, 2016
The Ethylene Oxide Sterilization Association, Inc. Managed by B&C Consortia Management, L.L.C. POSITION STATEMENT Use of Ethylene Oxide The Ethylene Oxide Sterilization Association, Inc. (EOSA) would like
More informationQuality Control EQUIPMENT CONTROL. Monitor critical performance characteristics of sterilization, decontamination or cleaning equipment
STERILITY ASSURANCE Monitor critical performance characteristics of sterilization, decontamination or cleaning equipment VERIFY Equipment Control Products EQUIPMENT CONTROL LOAD CONTROL PROCESS CONTROL
More informationISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 14160 First edition 1998-03-15 Sterilization of single-use medical devices incorporating materials of animal origin Validation and routine control of sterilization by liquid
More informationAutoclave Installation and Operation Guidelines
Autoclave Installation and Operation Guidelines Part 70 of Title 10 (Health) of the official Compilation of Codes, Rules and Regulations of the State of New York (10 NYCRR Part 70) states that a facility
More informationGuidance. Media Fills for Validation of Aseptic Preparations for Positron Emission Tomography (PET) Drugs DRAFT GUIDANCE
Guidance Media Fills for Validation of Aseptic Preparations for Positron Emission Tomography (PET) Drugs DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and
More informationGuidance for FDA Reviewers
Guidance for FDA Reviewers Premarket Notification Submissions for Empty Containers for the Collection and Processing of Blood and Blood Components Comments and suggestions regarding this document may be
More informationDisinfection Qualification Testing
Disinfection Qualification Testing Considerations for Aseptic & Cleanroom Manufacturing Environments White Paper Considerations for Aseptic and Cleanroom Manufacturing Environments Obtaining the highest
More informationH2O Express. A pasteurization case study
H2O Express A pasteurization case study Pasteurization The reduction of bacterial contamination by thermal, chemical, irradiation, or other modality 5-log reduction standard Exceptions for 4-log reduction
More informationNovember 18, Andersen Sterilizers, Inc. Dr. William Andersen President 3154 Caroline Drive Haw River, North Carolina 27258
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 November 18, 2015 Andersen
More information3M TM Attest TM 1262-S Biological Indicator for Steam 3M TM Attest TM Incubator. Product. Profile. For Industrial Applications
3M TM Attest TM 1262-S Biological Indicator for Steam 3M TM Attest TM Incubator Product Profile For Industrial Applications Table of Contents Product Description... 3 Regulatory Status... 4 Product Specification
More informationSecure. Tested. Certified.
Secure. Tested. Certified. We solve problems with confidence and creativity. Monitoring Products for Dry Heat DRY Steam-Formaldehyde Chlorine Dioxide FORM CL02 NAMSA s Sterilization Products Division manufactures
More informationCDRH Device Approval
CDRH Device Approval Mary S. Pastel, ScD Deputy Director for Radiological Health Office of In Vitro Diagnostics and Radiological Health (OIR) Center for Devices and Radiological Health (CDRH) US Food and
More informationInnovative H 2 O 2 V-Phase biodecontamination solutions
Innovative H 2 O 2 V-Phase biodecontamination solutions ENEMY ZERO H 2 O 2 V-Phase = 6 Log reduction The right solution to eliminate a wide spectrum of microorganisms quickly and effectively. The presence
More informationProduct. Profile. For Industrial Applications. Medical Sterilization Specialties
Medical Sterilization Specialties 3M TM Attest TM 1264-S Biological Indicator for Ethylene Oxide 3M TM Attest TM Incubators Product Profile For Industrial Applications Table of Contents Product Description...
More informationMICROBIOLOGICAL VALIDATION PROGRAMME FOR SRCL CLINICAL WASTE TREATMENT AUTOCLAVE PROCESSING METALS (SINGLE USE DEVICES) AT LEEDS
MICROBIOLOGICAL VALIDATION PROGRAMME FOR PROCESSING METALS (SINGLE USE DEVICES) AT LEEDS M G Holliday MBA, PhD, MSc, CSci, FIBMS. MCIWM. F InstLM. Microbiology Department Freeman Hospital Newcastle upon
More informationRaven Labs. Sterility Assurance for Industry. Sterility Assurance Products Since A division of Mesa Laboratories, Inc.
Raven Labs A division of Mesa Laboratories, Inc. Sterility Assurance for Industry Sterility Assurance Products Since 1949 Industrial Use Biological Indicators Most co mmercially available Biologi cal Indicators
More informationISO Part 1 and Part 2 Compliance Requirements. Cathriona O Neill
ISO 11607 Part 1 and Part 2 Compliance Requirements Cathriona O Neill I.S. EN 11607 Introduction ISO 11607 is the principal guidance document. Packaging for terminally sterilised medical devices - Part
More informationAAMI Quality Systems White Paper
AAMI s White Paper Comparison of 21 CFR Part 820 to ISO 13485:2016 February 2017, Updated February 2018 AUTHORS Seb Clerkin, GMP Advisory Services Nicola Martin, Owner, Nicola Martin Consulting Jack Ward,
More informationRisk based approaches for a sterility assurance application review: a microbiologist s perspective Dr. Yeissa Chabrier Roselló
Risk based approaches for a sterility assurance application review: a microbiologist s perspective Dr. Yeissa Chabrier Roselló Product Quality Microbiologist Division of Microbiology Assessment Office
More informationNavigating the FDA, and understanding Medical Device Preemption. Special Counsel Foulston Siefkin
Navigating the FDA, and understanding Medical Device Preemption Presented by Cydney Boler Special Counsel Foulston Siefkin cboler@foulston.com 913-253-2158 March 9, 2010 A bit of Legalese upfront: The
More informationMarch 19, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane Room 1061 Rockville, MD 20852
March 19, 2018 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane Room 1061 Rockville, MD 20852 RE: Docket No. FDA-2017-D-6765; Draft Guidance for Industry and Food
More informationHow Pre-Validated Medical Device Packaging Complies with ISO Standards
How Pre-Validated Medical Device Packaging Complies with ISO Standards Introduction There is a lot of excitement in the medical device packaging industry about pre-validated packaging. Using pre-validated
More informationDecontamination Effectiveness of Esco Celsafe CO2 Incubator Sterilization Feature using High Heat Temperature By Bekti Tri Sumaryati
Decontamination Effectiveness of Esco Celsafe CO2 Incubator Sterilization Feature using High Heat Temperature By Bekti Tri Sumaryati 1. Summary Esco Celsafe CO 2 Incubator sterilization feature, which
More informationLec.5 Food Microbiology Dr. Jehan Abdul Sattar
Lec.5 Food Microbiology Dr. Jehan Abdul Sattar High-Temperature Food Preservation: The use of high temperatures to preserve food is based on their destructive effects on microorganisms. Depending on the
More informationGeneral Comments. May 30, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852
701 Pennsylvania Avenue, Ste. 800 Washington, DC 20004 2654 Tel: 202 783 8700 Fax: 202 783 8750 www.advamed.org Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane,
More informationDISINFECTION QUALIFI CATION TESTING CONSIDERATIONS FOR THE ASEPTIC AND CLEANROOM MANUFACTURING ENVIRONMENT
DISINFECTION QUALIFI CATION TESTING CONSIDERATIONS FOR THE ASEPTIC AND CLEANROOM MANUFACTURING ENVIRONMENT by Dave Rottjakob, M.T. (ASCP) December, 2013 INTRODUCTION Obtaining the highest confidence that
More informationThis document is a preview generated by EVS
INTERNATIONAL STANDARD ISO 13408-2 Second edition 2018-01 Aseptic processing of health care products Part 2: Sterilizing filtration Traitement aseptique des produits de santé Partie 2: Filtration stérilisante
More informationScott Colburn, CAPT USPHS Director, FDA/CDRH Standards Program
Scott Colburn, CAPT USPHS Director, FDA/CDRH Standards Program MEDICAL DEVICE STANDARDS: HARMONIZATION AND REGULATORY CONVERGENCE IN SUPPORT OF HEALTH CARE SECTOR SERVICES 1 Why Participate? ROLE OF THE
More informationISO INTERNATIONAL STANDARD
INTERNATIONAL STANDARD ISO 11135-1 First edition 2007-05-01 Sterilization of health care products Ethylene oxide Part 1: Requirements for development, validation and routine control of a sterilization
More informationTECHNICAL DATASHEET. in compliance with: USP, ISO and all appropriate subsections FQ 106 v3.0 August, 2015
ETIGAM TECHNICAL DATASHEET ETIGAM NSS biological indicator spore strips for radiation Bacillus pumilus This technical report provides relevant data and instructions for use of the NSS biological indicator
More informationGB / ISO :2006
Translated English of Chinese Standard: GB18281.1-2015 www.chinesestandard.net Sales@ChineseStandard.net ICS 11.080.01 C 47 NATIONAL STANDARD OF THE PEOPLE'S REPUBLIC OF CHINA GB / ISO 11138-1:2006 Replacing
More informationDrug Good Manufacturing Practices Inspections
Drug Good Manufacturing Practices Inspections New England District Investigations Branch Parenteral Drug Association New England Chapter May 17, 2006 DRUG MANUFACTURING INSPECTIONS Inspections Include:
More informationOverview of Biomarker Qualification. Marc K Walton MD, PhD Office of Translational Sciences CDER-FDA
Overview of Biomarker Qualification Marc K Walton MD, PhD Office of Translational Sciences CDER-FDA Categories of Biomarkers Prognostic Predictive Pharmacodynamic Including adverse response Efficacy-response
More informationStandards: Overview and Up-date
Standards: Overview and Up-date Quality Assurance in CSSD by Compliance to Standards Klaus Hahnen, 3M, Germany Purpose of the Presentation Provide a brief introduction to standards, standardization bodies
More informationPART 58 GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES
Part 58-explanation of changes Scope ( 58.1) We propose to expand the scope of FDA-regulated nonclinical laboratory studies to specifically include toxicity studies. For purposes of this proposal, toxicity
More informationPART 58 GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES
Part 58-explanation of changes Scope ( 58.1) We propose to expand the scope of FDA-regulated nonclinical laboratory studies to specifically include toxicity studies. For purposes of this proposal, toxicity
More informationPart 2: Sterilizing filtration
Provläsningsexemplar / Preview INTERNATIONAL STANDARD ISO 13408-2 Second edition 2018-01 Aseptic processing of health care products Part 2: Sterilizing filtration Traitement aseptique des produits de santé
More informationBIOCOMPATIBILITY TESTING OF GAS PATHWAYS IN MEDICAL DEVICES
BIOCOMPATIBILITY TESTING OF GAS PATHWAYS IN MEDICAL DEVICES EXECUTIVE SUMMARY Many medical devices used to assist in the diagnosis, monitoring or treatment of respiratory issues or to deliver anesthesia
More informationValidation and Control of Porous Load Sterilisation
Validation and Control of Porous Load Sterilisation Crown Plaza Hotel, Santry; October 14 th 2010 Gerard Sheridan 14th October 2010 Slide 1 14th October 2010 Slide 2 14th October 2010 Slide 3 Overview
More informationThis document is a preview generated by EVS
INTERNATIONAL STANDARD ISO 14160 Second edition 2011-07-01 Sterilization of health care products Liquid chemical sterilizing agents for single-use medical devices utilizing animal tissues and their derivatives
More informationBFS IOA BFS Training 2018 Kunming Qualification and Validation of a BFS-Installation including CIP/SIP
Qualification and Validation of a BFS-Installation including CIP/SIP Presented by Christoph Bohn and Stefan Kiesel Director Rommelag Pharma Service Senior Manager Rommelag Pharma Service Coyright BFS IOA
More informationMetrics in Microbiology Monitoring Practices
Metrics in Microbiology Monitoring Practices Crystal Booth, M.M. Masters of Microbiology from North Carolina State University Former Associate Director of Microbiology at Novartis Metrics in Microbiology
More informationCYCLE DEVELOPMENT. Michael S. Korczynski. MIKKOR Enterprises, Inc. Lake Bluff, IL. Jeanne Moldenhauer
5481 DHI Pub Ch11I 10/18/02 6:46 PM Page 353 11 CYCLE DEVELOPMENT Michael S. Korczynski MIKKOR Enterprises, Inc. Lake Bluff, IL Jeanne Moldenhauer Vectech Pharmaceutical Consultants, Inc. Farmington Hills,
More informationIN THIS SECTION MICROBIOLOGY TESTING EXPERT SOLUTIONS FOR PRODUCT DEVELOPMENT. Bacterial Endotoxin (LAL) Testing
EXPERT SOLUTIONS FOR PRODUCT DEVELOPMENT IN THIS SECTION MICROBIOLOGY TESTING Microbial assays involve a variety of tests, from the determination of the numbers and types of organisms naturally present
More informationInstructions for Validation of Autoclaves
Instructions for Validation of Autoclaves A. Validation of autoclaves may accomplished by the following methods: 1. Autoclave tape applied to the outside of all packs to validate that the correct temperature
More informationFZ LABORATORY SERVICES
FZ LABORATORY SERVICES For those working in biological product manufacturing/aseptic process filling: you can greatly benefit from support by Franz Ziel GmbH (FZ) with many years experience in scientific
More informationRegulatory Approach to Nanotechnology-Based Drugs For Animals
Regulatory Approach to Nanotechnology-Based Drugs For Animals Steven Fleischer, DVM CSL/JIFSAN Joint Symposium on Food Safety and Nutrition: Nanotechnology in Foods and Cosmetics June 28, 2007 Introduction
More informationComplaints Investigations Root Cause Analysis
Complaints Investigations Root Cause Analysis Dr. Ademola Daramola International Relations Specialist Drugs US FDA India Office New Delhi February 22nd 2018 Information presented in this presentation does
More informationIn recent years formal process risk
FOCUS ON... COMPLIANCE Process Risk Profile Documents Effective Risk Communication Between Product Development and Operations by Carol DeSain In recent years formal risk assessment (RA) has become common
More informationContains Nonbinding Recommendations
Mitigating the Risk of Cross- Contamination from Valves and Accessories Used for Irrigation Through Flexible Gastrointestinal Endoscopes Guidance for Industry and Food and Drug Administration Staff Document
More informationDistinguishing Medical Device Recalls from Product Enhancements and Associated Reporting Requirements
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Distinguishing Medical Device Recalls from Product Enhancements and Associated Reporting Requirements Draft Guidance for Industry
More informationDraft Guidance for Industry, Clinical Laboratories, and FDA Staff. In Vitro Diagnostic Multivariate Index Assays
Draft Guidance for Industry, Clinical Laboratories, and FDA Staff In Vitro Diagnostic Multivariate Index Assays DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Document
More information3M Life Science Sterilization Product Portfolio More control. More confidence.
3M Life Science Sterilization Product Portfolio More control. More confidence. Solutions for medical device and pharmaceutical sterilization processes 3M Life Science Sterilization Product Portfolio Setting
More informationLow Temperature Processing. An Update on Guidelines, Standards and Requirements
Low Temperature Processing An Update on Guidelines, Standards and Requirements Continuing Education Contact Hours Participants must complete the entire presentation/seminar to achieve successful completion
More informationFDA > CDRH > CFR Title 21 Database Search
Seite 1 von 7 FDA Home Page CDRH Home Page Search A-Z Index 510 (k) Registration Listing Adverse Events PMA Classification CLIA CFR Title 21 Advisory Committees Assembler Recalls Guidance Standards New
More informationContains Nonbinding Recommendations. Draft Not for Implementation
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 Information to Support a Claim of Electromagnetic Compatibility (EMC) of Electrically-Powered Medical Devices Draft
More informationEarly Feasibility Study (EFS) IDEs
Early Feasibility Study (EFS) IDEs A Valuable Regulatory Tool for Medical Device Development Carla M. Wiese Policy Analyst for the Early Feasibility Program Office of Device Evaluation Center for Devices
More informationEffective Heat Sterilization in CO 2 Incubators
Effective Heat Sterilization in CO 2 Incubators Volume 4, Number 3 Key Words Key Words Class 100 air Contamination control Contamination elimination HEPA filtration Incubator Heat Sterilization White Paper
More informationMEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155
MEDICAL DEVICE CLINICAL INVESTIGATIONS AND ISO 14155 EXECUTIVE SUMMARY Medical device regulations around the world generally require manufacturers of most types of medical devices to supply data as part
More informationEuropean Packaging Regulations What to expect from a notified body audit of your packaging
What to expect from a notified body audit of your packaging Dr. Ralf Walther TÜV Süd Product Service GmbH March 3-5, 2009 www.healthpack.net Content 1. Short introduction of TÜV Süd Product Service 2.
More informationIDT Australia Ltd. 5/23/18
IDT Australia Ltd. 5/23/18 10903 New Hampshire Avenue Silver Spring, MD 20993 Via UPS Warning Letter 320-18-55 Return Receipt Requested May 23, 2018 Dr. Graeme R. Kaufman CEO, Acting, and Chairman of the
More informationWhy Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services
Why Do I Test, What Do I Test & When Do I Test It? Ross Caputo, PhD Chief Technical Officer Eagle Analytical Services Disclosures I, Ross Caputo, declare no conflicts of interest, real or apparent, and
More informationHow is Sterilization Validation Performed by the Medical Device Manufacturer?
How is Sterilization Validation Performed by the Medical Device Manufacturer? Rod Parker, Ph.D. Sr. Principal Scientist Stryker Instruments Division May 9, 2016 DISCLOSURE I am an employee of Stryker Corporation.
More informationGuidance for Industry
Guidance for Industry Heparin for Drug and Medical Device Use: Monitoring Crude Heparin for Quality DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions
More informationValidation of cleaning and sterilization of reusable medical devices
Synergy makes sence Validation of cleaning and sterilization of reusable medical devices MG-FSI72-119 Last revision: June 2012 Aurélien BIGNON 5, Chemin du Catupolan - 69120 Vaulx en Velin - France - Tel.
More informationGuidance for Industry and FDA Staff. Replacement Reagent and Instrument Family Policy
Guidance for Industry and FDA Staff Replacement Reagent and Instrument Family Policy Document issued on: December 11, 2003 This document supersedes Data for Commercialization of Original Equipment Manufacturers
More information